US equities |
SPCX $168.70 ▲+6.13% NVDA $237.44 ▲+1.49% MU $1,065.13 ▼-0.91% TSLA $379.84 ▲+2.50% MSFT $524.88 ▲+1.42% SNDK $1,714.36 ▼-0.33% INTC $116.83 ▼-2.10% META $744.07 ▲+2.20%
FinancialContent

Articles published by NANOBOTIX

News headline image
NANOBOTIX: New Preclinical Immunotherapy Data Show Boosted Anti-Tumor Immune Activation via Triple Blockade of PD-1, LAG-3, and TIGIT When Combined With Radiotherapy-Activated NBTXR3
From NANOBOTIX
Via Business Wire
Tickers NBTX